Search results
Results from the WOW.Com Content Network
FibroGen (FGEN) delivered earnings and revenue surprises of -113.24% and 62.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
This month, we saw the FibroGen, Inc. ( NASDAQ:FGEN ) up an impressive 32%. But spare a thought for the long term...
Last week, the AdCom delivered an “overwhelmingly” one-sided vote against the treatment’s approval; 13-1 on the decision whe Don’t Go Bargain Hunting on FibroGen Stock, Says Analyst Skip ...
No one likes being given the wrong information. Investors reacted in dismay and sent Fibrogen (FGEN) shares deep into the red following the company's embarrassing announcement. The biotech company ...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us